AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma

Sikander Ailawadhi, Ricardo D. Parrondo, Navnita Dutta, Bing Han, Gina Ciccio, Yesesri Cherukuri, Victoria R. Alegria, Betsy R. LaPlant, Vivek Roy, Taimur Sher, Brett Edwards, Stephanie Lanier, Alak Manna, Keisha Heslop, Thomas Caulfield, Emir Maldosevic, Peter Storz, Rami Manochakian, Yan Asmann, Asher A. Chanan-Khan, Aneel Paulus

Open source

DOI: 10.3390/cancers15020477
Published: 2023-01-12
Container: Cancers
Publisher: MDPI AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers15020477,
  title = {AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma},
  author = {Sikander Ailawadhi and Ricardo D. Parrondo and Navnita Dutta and Bing Han and Gina Ciccio and Yesesri Cherukuri and Victoria R. Alegria and Betsy R. LaPlant and Vivek Roy and Taimur Sher and Brett Edwards and Stephanie Lanier and Alak Manna and Keisha Heslop and Thomas Caulfield and Emir Maldosevic and Peter Storz and Rami Manochakian and Yan Asmann and Asher A. Chanan-Khan and Aneel Paulus},
  year = {2023},
  journal = {Cancers},
  doi = {10.3390/cancers15020477},
  url = {https://doi.org/10.3390/cancers15020477}
}

RIS

TY  - JOUR
TI  - AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
AU  - Sikander Ailawadhi
AU  - Ricardo D. Parrondo
AU  - Navnita Dutta
AU  - Bing Han
AU  - Gina Ciccio
AU  - Yesesri Cherukuri
AU  - Victoria R. Alegria
AU  - Betsy R. LaPlant
AU  - Vivek Roy
AU  - Taimur Sher
AU  - Brett Edwards
AU  - Stephanie Lanier
AU  - Alak Manna
AU  - Keisha Heslop
AU  - Thomas Caulfield
AU  - Emir Maldosevic
AU  - Peter Storz
AU  - Rami Manochakian
AU  - Yan Asmann
AU  - Asher A. Chanan-Khan
AU  - Aneel Paulus
PY  - 2023
JO  - Cancers
DO  - 10.3390/cancers15020477
UR  - https://doi.org/10.3390/cancers15020477
ER  -

APA

Ailawadhi, S., Parrondo, R. D., Dutta, N., Han, B., Ciccio, G., Cherukuri, Y., Alegria, V. R., LaPlant, B. R., Roy, V., Sher, T., Edwards, B., Lanier, S., Manna, A., Heslop, K., Caulfield, T., Maldosevic, E., Storz, P., Manochakian, R., Asmann, Y., Chanan-Khan, A. A., & Paulus, A. (2023). AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma. Cancers. https://doi.org/10.3390/cancers15020477

Source records

crossref · retrieved 2026-09-25T22:44:25.031Z